13.24
전일 마감가:
$12.51
열려 있는:
$12.5
하루 거래량:
37,057
Relative Volume:
1.23
시가총액:
$27.11M
수익:
-
순이익/손실:
$-4.85M
주가수익비율:
-42.73
EPS:
-0.31
순현금흐름:
$-3.95M
1주 성능:
+2.20%
1개월 성능:
+21.51%
6개월 성능:
-23.88%
1년 성능:
+64.53%
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
명칭
Cadrenal Therapeutics Inc
전화
904-300-0701
주소
822 A1A NORTH, PONTE VEDRA
CVKD을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CVKD
Cadrenal Therapeutics Inc
|
13.24 | 25.61M | 0 | -4.85M | -3.95M | -0.31 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-12-18 | 개시 | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc 주식(CVKD)의 최신 뉴스
Is Cadrenal Therapeutics Inc. on track to beat earnings2025 Trading Volume Trends & Community Driven Trade Alerts - خودرو بانک
Can Cadrenal Therapeutics Inc. weather a recessionJuly 2025 Update & Entry Point Confirmation Signals - خودرو بانک
Is Cadrenal Therapeutics Inc. forming a bullish divergenceJuly 2025 Highlights & Daily Risk Controlled Trade Plans - خودرو بانک
What momentum shifts mean for Cadrenal Therapeutics Inc.Analyst Upgrade & Scalable Portfolio Growth Methods - Newser
Cadrenal Therapeutics Inc. Recovery Linked to Earnings SurpriseJuly 2025 Selloffs & Long-Term Safe Investment Plans - beatles.ru
Will Cadrenal Therapeutics Inc. outperform the marketVolume Spike & Daily Market Momentum Tracking - Newser
Aug Rallies: What is Cadrenal Therapeutics Inc.’s valuation compared to sectorWeekly Trend Recap & Daily Profit Maximizing Tips - خودرو بانک
Cadrenal Therapeutics Inc. recovery potential after sell offMarket Risk Summary & Entry Point Strategy Guides - Newser
Short interest data insights for Cadrenal Therapeutics Inc.Weekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Is Cadrenal Therapeutics Inc. stock ready for a breakoutIndex Update & Stock Portfolio Risk Management - Newser
How to build a custom watchlist for Cadrenal Therapeutics Inc.Swing Trade & Expert Curated Trade Setups - Newser
Custom strategy builders for tracking Cadrenal Therapeutics Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
How to build a dashboard for Cadrenal Therapeutics Inc. stockWeekly Trend Recap & Reliable Intraday Trade Plans - Newser
Is this a good reentry point in Cadrenal Therapeutics Inc.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - Newser
Cadrenal Therapeutics Inc. stock outlook for YEARFed Meeting & Risk Controlled Stock Pick Alerts - Newser
Using AI based signals to follow Cadrenal Therapeutics Inc.2025 Price Targets & Expert Curated Trade Setup Alerts - Newser
How institutional ownership impacts Cadrenal Therapeutics Inc. stockJuly 2025 Retail & AI Based Buy/Sell Signal Reports - Newser
Is Cadrenal Therapeutics Inc. stock forming a cup and handlePortfolio Update Report & Stock Market Timing Techniques - خودرو بانک
What high frequency data says about Cadrenal Therapeutics Inc.July 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Should you wait for a breakout in Cadrenal Therapeutics Inc.Quarterly Performance Summary & Risk Adjusted Swing Trade Ideas - Newser
Is a relief rally coming for Cadrenal Therapeutics Inc. holdersQuarterly Profit Review & Smart Allocation Stock Tips - Newser
How to track smart money flows in Cadrenal Therapeutics Inc.Gap Up & High Accuracy Investment Signals - Newser
Will Cadrenal Therapeutics Inc. benefit from macro trendsPortfolio Value Summary & Growth Oriented Trade Recommendations - Newser
How to read the order book for Cadrenal Therapeutics Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
Market Overview: Can Cadrenal Therapeutics Inc. navigate macro headwindsJuly 2025 Outlook & Daily Chart Pattern Signal Reports - خودرو بانک
News impact scoring models applied to Cadrenal Therapeutics Inc.Market Volume Summary & Stepwise Entry/Exit Trade Alerts - Newser
Is a relief rally coming for FTRE holdersWeekly Stock Report & Weekly Setup with High ROI Potential - Newser
Real time social sentiment graph for Churchill Downs IncorporatedJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Intraday pattern recognizer results for Cadrenal Therapeutics Inc.2025 Trading Recap & Growth Oriented Trade Recommendations - Newser
Fed Meeting: Can Cadrenal Therapeutics Inc. weather a recessionJuly 2025 Short Interest & Free Risk Controlled Daily Trade Plans - خودرو بانک
Cadrenal Therapeutics (NASDAQ:CVKD) Trading Down 2.5% Following Insider Selling - Defense World
Live market analysis of Cadrenal Therapeutics Inc.2025 Big Picture & Precise Entry and Exit Recommendations - Newser
What is Cadrenal Therapeutics Inc.’s valuation compared to sectorTrade Exit Summary & Long-Term Capital Growth Ideas - خودرو بانک
Market reaction to Cadrenal Therapeutics Inc.’s recent news2025 Big Picture & Safe Capital Growth Tips - Newser
What to do if you’re stuck in FirstService CorporationEarnings Overview Summary & Fast Momentum Stock Entry Tips - Newser
Identifying reversal signals in Cadrenal Therapeutics Inc.2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Can momentum traders help lift Cadrenal Therapeutics Inc.Weekly Trend Recap & Technical Pattern Based Signals - Newser
Published on: 2025-08-31 17:29:05 - Newser
Cadrenal Therapeutics Inc (CVKD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cadrenal Therapeutics Inc 주식 (CVKD) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Szot Matthew K | Chief Financial Officer |
Aug 28 '25 |
Sale |
14.00 |
400 |
5,600 |
31,333 |
Pham Quang X | CEO and Chairman |
Aug 27 '25 |
Sale |
13.99 |
3,836 |
53,666 |
214,497 |
Pham Quang X | CEO and Chairman |
Aug 28 '25 |
Sale |
13.99 |
1,193 |
16,690 |
213,304 |
자본화:
|
볼륨(24시간):